Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2/3 Double Blinded, Randomized, Placebo-controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of an Inactivated A/H5N1 Influenza Vaccine (IVACFLU-A/H5N1) Produced by IVAC

NCT02612909 is registered in ClinicalTrials.gov with Institute of Vaccines and Medical Biologicals, Vietnam as lead sponsor.

NCT NCT02612909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2/3 Double Blinded, Randomized, Placebo-controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of an Inactivated A/H5N1 Influenza Vaccine (IVACFLU-A/H5N1) Produced by IVAC
Lead sponsor
Institute of Vaccines and Medical Biologicals, Vietnam
Phase
Phase 2/3
Overall status
Completed
Start date
March 7, 2017
Completion date
August 30, 2017
Enrollment
930 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

avian influenza